Express Scripts Holding (ESRX) Stake Decreased by Gabelli Funds LLC

Gabelli Funds LLC decreased its holdings in Express Scripts Holding (NASDAQ:ESRX) by 3.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 107,000 shares of the company’s stock after selling 4,000 shares during the period. Gabelli Funds LLC’s holdings in Express Scripts were worth $7,986,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Stonebridge Capital Advisors LLC boosted its stake in shares of Express Scripts by 0.4% in the second quarter. Stonebridge Capital Advisors LLC now owns 24,059 shares of the company’s stock worth $1,536,000 after acquiring an additional 100 shares during the period. National Asset Management Inc. boosted its stake in shares of Express Scripts by 1.5% in the second quarter. National Asset Management Inc. now owns 7,939 shares of the company’s stock worth $510,000 after acquiring an additional 115 shares during the period. San Francisco Sentry Investment Group CA boosted its stake in shares of Express Scripts by 3.2% in the second quarter. San Francisco Sentry Investment Group CA now owns 4,487 shares of the company’s stock worth $286,000 after acquiring an additional 138 shares during the period. L & S Advisors Inc boosted its stake in shares of Express Scripts by 2.3% in the second quarter. L & S Advisors Inc now owns 6,140 shares of the company’s stock worth $392,000 after acquiring an additional 140 shares during the period. Finally, Westside Investment Management Inc. boosted its stake in shares of Express Scripts by 2.5% in the second quarter. Westside Investment Management Inc. now owns 8,336 shares of the company’s stock worth $515,000 after acquiring an additional 200 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

In other Express Scripts news, VP Glen D. Stettin sold 3,449 shares of the company’s stock in a transaction that occurred on Thursday, January 11th. The stock was sold at an average price of $81.00, for a total transaction of $279,369.00. Following the sale, the vice president now directly owns 33,715 shares in the company, valued at $2,730,915. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Glen D. Stettin sold 3,448 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total value of $262,048.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 17,001 shares of company stock worth $1,249,505. Company insiders own 0.68% of the company’s stock.

Shares of Express Scripts Holding (NASDAQ:ESRX) opened at $71.71 on Friday. Express Scripts Holding has a 52-week low of $55.80 and a 52-week high of $83.49. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The stock has a market capitalization of $40,614.61, a P/E ratio of 10.48, a price-to-earnings-growth ratio of 0.79 and a beta of 0.93.

Express Scripts announced that its Board of Directors has initiated a share repurchase plan on Monday, December 18th that authorizes the company to buyback 45,000,000 outstanding shares. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s board of directors believes its stock is undervalued.

A number of equities analysts recently commented on ESRX shares. Maxim Group increased their price target on Express Scripts from $78.00 to $87.00 and gave the company a “buy” rating in a research note on Thursday, December 14th. Deutsche Bank started coverage on Express Scripts in a research note on Monday, December 4th. They set a “buy” rating and a $75.00 price target for the company. Zacks Investment Research lowered Express Scripts from a “buy” rating to a “sell” rating in a research note on Tuesday, October 24th. Royal Bank of Canada set a $66.00 price target on Express Scripts and gave the company a “hold” rating in a research note on Wednesday, October 25th. Finally, SunTrust Banks set a $86.00 price target on Express Scripts and gave the company a “buy” rating in a research note on Thursday, December 21st. Six research analysts have rated the stock with a sell rating, eight have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $78.23.

COPYRIGHT VIOLATION WARNING: This piece of content was published by Week Herald and is owned by of Week Herald. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at https://weekherald.com/2018/02/11/express-scripts-holding-esrx-stake-decreased-by-gabelli-funds-llc.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply